This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in total membership.
The Zacks Analyst Blog Highlights: Houlihan Lokey, Crocs and Community Health Systems
by Zacks Equity Research
Houlihan Lokey, Crocs and Community Health Systems are highlighted in this Analyst Blog article.
A Window to Buy 3 Great Stocks Ahead of Earnings
by Sejuti Banerjea
Things are coming together for HLI, CROX and CYH.
Retail Loss to Affect Humana's (HUM) Q4 Earnings: Here's How
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to reflect growth in medical membership.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 results reflect better revenues and a solid contribution from its Government Business and IngenioRx businesses, partly offset by escalating expenses.
Is Community Health Systems (CYH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Community Health Systems (CYH) and LumiraDx Limited (LMDX) have performed compared to their sector so far this year.
Why Fast-paced Mover Community Health Systems (CYH) Is a Great Choice for Value Investors
by Zacks Equity Research
Community Health Systems (CYH) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Best Momentum Stocks to Buy for January 25th
by Zacks Equity Research
PFBC, CYH, and HBNC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 25, 2022
Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have gained from rising admissions and higher revenues.
Community Health (CYH) Unit Declares Pricing of Senior Notes
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by pricing senior notes to procure funds.
Why Seasoned Investors are Retaining Community Health (CYH)
by Zacks Equity Research
Community Health Systems (CYH) is focused on making strategic acquisitions to boost its business through inorganic growth.
Encompass Health (EHC) Forms JV, Boosts Presence in Idaho
by Zacks Equity Research
Encompass Health (EHC) forms a JV with Saint Alphonsus for offering better home health and hospice services across Idaho.
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Community Health Systems, Mednax, HCA Healthcare and Tenet Healthcare
3 Hospital Stocks That Crushed S&P 500 YTD, Set to Rise Further
by Srijita Guha
High patient volumes, mergers and buyouts, and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH.
Encompass Health (EHC) Unveils 40-Bed Hospital Plan in Ohio
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct an inpatient rehabilitation hospital in Ohio, which aims to facilitate improved rehabilitation services throughout the state.
Community Health (CYH) Up 64% YTD: More Growth Potential Left?
by Zacks Equity Research
Community Health Systems' (CYH) cost-control initiatives are likely to lower costs to a great extent and boost the bottom line.
Why Investors Should Hold on to Universal Health (UHS) Stock
by Zacks Equity Research
Universal Health (UHS) can bank on balance sheet strength for future acquisitions to grow its business inorganically.
Community Health Systems (CYH) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Community Health Systems (CYH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Why Community Health (CYH) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Community Health (CYH).
Tenet Healthcare (THC) and USPI Strike SurgeryCenter Deal
by Zacks Equity Research
Tenet Healthcare (THC) along with its subsidiary to acquire SurgCenter Development (SCD) for $1.2 billion.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fast-paced Momentum Stock Community Health Systems (CYH) Is Still Trading at a Bargain
by Zacks Equity Research
Community Health Systems (CYH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Best Growth Stocks to Buy for October 29th
by Zacks Equity Research
CYH, RVLV, ARCB, and SONO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 29, 2021.
Community Health's (CYH) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) third-quarter earnings gain from a solid revenue stream and lower expenses.
HCA Healthcare (HCA) Up 109.5% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) cost-curbing measures, strategic initiatives and a solid guidance are likely to bump up its shares.